McKesson Corporation – Consensus Indicates Potential 6.5% Upside McKesson Corporation with ticker code (MCK) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 409 and 320 calculating the average target price we see 377.92. Now with the previous closing price of 354.77 this would imply there is a potential upside of 6.5%. The day 50 moving average is 326.01 and the 200 moving average now moves to 284.34. The company has a market cap of $51,687m. Company Website: https:||www.mckesson.com [stock_market_widget type="chart" template="basic" color="green" assets="MCK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $55,059m based on the market concensus. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S.